CYBEX Launches Second Annual ‘Pink Ribbon Run’ Supporting Breast Cancer Research

Cybex International, Inc. (NASDAQ: CYBI), a leading manufacturer of premium exercise equipment, announced today its 2nd Annual Pink Ribbon Run, a national program benefitting The Breast Cancer Research Foundation (BCRF) through which CYBEX donates $0.10 for each mile logged on its custom-made pink treadmills during Breast Cancer Awareness Month – October, 2010.

The distinctive pink treadmills, manufactured in Medway, MA, will be sold to health clubs, YMCA’s and other exercise facilities across the country. Information on participating clubs and purchasing details are available at www.cybexintl.com/pinkribbonrun.

During its inaugural campaign, Pink Ribbon Run was recognized as one of 2009’s top cause-marketing initiatives, with exercisers logging more than 250,000 miles on the pink treadmills at more than 90 facilities in 38 states. Based on that success, for every one pink treadmill purchased by a repeat participant this year, a donation will be made for that treadmill, as well as one purchased in 2009.

"As a company, we’re deeply committed to raising funds to fight breast cancer, and awareness about the benefits of exercise as it relates to the disease,” states Joan Carter, CYBEX Executive Director and Founder of the CYBEX Pink Ribbon Run. "We were very pleased with the success of the Pink Ribbon Run last year, and so were the clubs and YMCA’s that participated. Our goal is to raise even more money in 2010.”

Breast cancer is the second leading cause of cancer death in women, according to The American Cancer Society, which estimates one out of every eight women will develop the disease. Research from The Nurses Health Study published in the Journal of American Medical Association (JAMA) tracked nearly 3,000 women up to 14 years after their breast cancer diagnosis and found that exercise reduced the likelihood of recurrence and increased the odds of living longer. It’s also been shown that exercise likely offers protection against breast cancer, regardless of a woman’s stage in life.

"This innovative program not only contributes to The Breast Cancer Research Foundation’s mission of finding a cure for this disease in our lifetime, it also draws tremendous attention to exercise as one of the most important preventative factors in relation to breast cancer,” states Myra J. Biblowit, BCRF President. "The 2nd Annual CYBEX Pink Ribbon Run is a cause any club can get behind, and it allows members to do more with the time they spend working out.”

About The Breast Cancer Research Foundation®

The Breast Cancer Research Foundation® was founded in 1993 by Evelyn H. Lauder as an independent, not-for-profit 501(c) (3) organization dedicated to funding innovative clinical and translational research. The Foundation supports scientists at top universities and academic medical centers worldwide conducting the most advanced and promising breast cancer research that will lead to prevention and a cure in our lifetime. A minimum of 85 cents of each dollar donated to the Foundation goes directly to breast cancer research and awareness programs. For more information, visit www.bcrfcure.org or call 1.866.FIND.A.CURE.

About CYBEX

Cybex International, Inc. is a leading manufacturer of premium exercise equipment primarily for commercial use. The CYBEX product line, including a full range of strength and cardio training machines, is designed using exercise science to reflect the natural movement of the human body. Led by the Cybex Institute for Exercise Science, CYBEX fitness equipment is engineered to produce optimal results for users from the first-time exerciser to the professional athlete. Products are available for a wide range of facilities, from commercial health clubs to home gyms, and are sold in more than 85 countries worldwide. For more information on CYBEX and its product lines, visit the Company’s website at www.cybexintl.com.

This news release may contain forward-looking statements. There are a number of risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made above. These include, but are not limited to, competitive factors, technological and product developments, market demand, economic conditions, the resolution of litigation involving the Company, and the ability of the Company to comply with the terms of its credit facilities. Further information on these and other factors which could affect the Company’s financial results can be found in the Company’s previously filed Report on Form 10-K for the year ended December 31, 2009, its Reports on Form 10-Q, its Current Reports on Form 8-K, and its proxy statement dated March 25, 2010.